.Pharmacolibrary.Drugs.ATC.N.N05BA06_1 .Pharmacolibrary.Drugs.ATC.N.N05BA06_1| name: | Lorazepam_1 |
| ATC code: | N05BA06_1 | route: | intravenous |
| n-compartments | 1 |
Lorazepam is a short-acting benzodiazepine used primarily to treat anxiety disorders, insomnia, status epilepticus, and as premedication for anesthesia. It has anxiolytic, sedative, anticonvulsant, and muscle relaxant properties. Lorazepam is widely approved and still clinically used today.
Pharmacokinetic parameters derived from healthy adults after intravenous administration.
Gonzalez, D, et al., & Capparelli, EV (2017). Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus. Clinical pharmacokinetics 56(8) 941–951. DOI:10.1007/s40262-016-0486-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27943220
Chamberlain, JM, et al., & van den Anker, JN (2012). Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. The Journal of pediatrics 160(4) 667–672.e2. DOI:10.1016/j.jpeds.2011.09.048 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22050870
Swart, EL, et al., & Strack van Schijndel, RM (2004). Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. British journal of clinical pharmacology 57(2) 135–145. DOI:10.1046/j.1365-2125.2003.01957.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/14748812